Trial
NCT04435015
The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
Ono Pharmaceutical Co., Ltd.
Condition
Coagulopathy
Intervention
Camostat Mesylate
Why stopped
No funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-18